Business Context and Reporting Period
Company: Aurora Innovation, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 31, 2024
Event: Entry into a Material Definitive Agreement for an underwritten public offering of Class A common stock.
Key Financial Metrics and Transaction Details
- Offering Size: 116,666,667 shares of Class A common stock (Firm Shares).
- Public Offering Price: $3.60 per share.
- Price to Company: $3.4830 per share.
- Expected Gross Proceeds: Approximately $420 million (before underwriting discounts, commissions, and expenses; assuming no exercise of the option).
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 17,500,000 additional shares.
- Expected Closing Date: August 2, 2024, subject to customary conditions.
Material Changes and Transaction Structure
This filing represents a material capital raise event rather than a periodic financial performance report. The company entered into an Underwriting Agreement with Goldman Sachs & Co. LLC, Allen & Company LLC, and Morgan Stanley & Co. LLC as representatives. The transaction is being made pursuant to an effective registration statement on Form S-3 (File No. 333-276317). The filing does not provide comparative financial metrics (revenue, profit, cash flow) for the period, as it focuses solely on the equity offering.
Guidance, Outlook, and Risks
Management Commentary: The company announced the commencement of the offering on July 31, 2024, and the pricing on August 1, 2024. The proceeds are intended to support the company's operations and strategic initiatives, though specific allocation details are not provided in this text.
Risks and Contingencies: The report includes standard forward-looking statement disclaimers. Key risks include:
- Uncertainty regarding the ability to consummate the proposed offering.
- Failure to satisfy closing conditions.
- Uncertainty regarding the exercise of the underwriters' option to purchase additional shares.
- General risks detailed in the Risk Factors section of the preliminary prospectus supplement and the company's Form 10-K.
Investor Verification Checklist
- Verify the final closing date and whether the underwriters exercised the 17,500,000 share over-allotment option.
- Review the final prospectus supplement for the exact amount of underwriting discounts and commissions to determine net proceeds.
- Confirm the dilution impact on existing shareholders based on the total shares issued (Firm Shares + any Over-Allotment).
- Examine the "Risk Factors" in the referenced Form S-3 and Form 10-K for specific operational and financial risks associated with the capital raise.